Trials / Conditions / Down Syndrome (Trisomy 21)

Down Syndrome (Trisomy 21)

14 registered clinical trials studyying Down Syndrome (Trisomy 21) — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation NCT06911944	Michael Rafii, MD, PhD	Phase 4
Recruiting	Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome NCT07195253	Hospices Civils de Lyon	—
Recruiting	Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromos NCT07493096	Healing Hope International	—
Enrolling By Invitation	Qualitative Effects of AEF0217 in Down Syndrome People NCT07413224	Aelis Farma	—
Not Yet Recruiting	The Neurocognitive Bases of Trust in Intellectual Disability NCT07434037	Hospices Civils de Lyon	—
Recruiting	AEF0217 in Participants With Down Syndrome NCT07334912	Aelis Farma	Phase 2
Recruiting	LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome NCT07234695	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Phase 3
Not Yet Recruiting	Neuropsychological Evaluation in Intellectual Disability (ENDI) NCT07047963	Central Hospital, Nancy, France	—
Enrolling By Invitation	Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adoles NCT06888570	IMDEA Food	—
Recruiting	Sleep Intervention and Quality of Life in Down Syndrome NCT06783725	University of Alabama at Birmingham	N/A
Completed	Cognitive Orientation to Daily Occupational Performance and Conductive Education Approaches on Down Syndrome NCT03687619	Eastern Mediterranean University	N/A
Completed	JASPER Intervention in Down Syndrome NCT03653143	Boston Children's Hospital	N/A
Unknown	Non-Invasive Determination of Fetal Chromosome Abnormalities NCT00891852	Lenetix Medical Screening Laboratory	—
Completed	Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker NCT00770458	Sequenom, Inc.	—